Yuchen Jiao, et al. raised that cholangiocarcinoma patients with IDH1 mutation compared to IDH1 wildtype patients had 3-year overall survival significantly reduced [10], which exposes that IDH1 mutations are key points in cholangiocarcinoma genesis. This evidence concerns the gene IDH1 and cholangiocarcinoma.